Future OTC Technologies Will Bring Regulatory Challenges – Gottlieb
This article was originally published in The Tan Sheet
Executive Summary
Technological changes in the OTC drug marketplace will prompt changes in the approval process for nonprescription products, according to FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb, MD